(IONS) Ionis Pharmaceuticals - Performance -33.2% in 12m
Compare IONS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-50.24%
#75 in Group
Rel. Strength
19.47%
#6153 in Universe
Total Return 12m
-33.23%
#74 in Group
Total Return 5y
-44.21%
#62 in Group
P/E -
(unknown) Percentile in Group
P/E Forward 90.9
92th Percentile in Group
PEG 25.7
100th Percentile in Group
FCF Yield -13.13%
33th Percentile in Group
12m Total Return: IONS (-33.2%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: IONS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IONS
Total Return (including Dividends) | IONS | XBI | S&P 500 |
---|---|---|---|
1 Month | -11.93% | -5.85% | -3.01% |
3 Months | -17.24% | -11.95% | -3.15% |
12 Months | -33.23% | -11.00% | 10.19% |
5 Years | -44.21% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | IONS | XBI | S&P 500 |
1 Month | -79.1% | -59.8% | -5.5% |
3 Months | -40.2% | -70.5% | -58.4% |
12 Months | -76.5% | -6.9% | 84.1% |
5 Years | -30.9% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #111 | -6.46% | -9.20% |
3 Month | #72 | -6.01% | -14.6% |
12 Month | #73 | -25.0% | -39.4% |
5 Years | #64 | -44.6% | -75.7% |
FAQs
Does IONS Ionis Pharmaceuticals outperforms the market?
No,
over the last 12 months IONS made -33.23%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months IONS made -17.24%, while XBI made -11.95%.
Over the last 3 months IONS made -17.24%, while XBI made -11.95%.
Performance Comparison IONS vs Indeces and Sectors
IONS vs. Indices IONS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -8.11% | -8.92% | -27.0% | -43.4% |
US NASDAQ 100 | QQQ | -7.13% | -7.87% | -26.2% | -41.8% |
US Dow Jones Industrial 30 | DIA | -8.31% | -9.79% | -27.9% | -42.7% |
German DAX 40 | DAX | -6.81% | -8.55% | -43.8% | -54.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | -7.82% | -12.2% | -11.7% | -42.4% |
Hongkong Hang Seng | HSI | -10.1% | -14.7% | -17.7% | -50.6% |
India NIFTY 50 | INDA | -9.14% | -19.8% | -16.6% | -33.9% |
Brasil Bovespa | EWZ | -8.22% | -20.2% | -19.0% | -21.5% |
IONS vs. Sectors IONS is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -6.57% | -8.12% | -35.1% | -52.4% |
Consumer Discretionary | XLY | -8.87% | -8.10% | -30.3% | -47.3% |
Consumer Staples | XLP | -10.9% | -10.1% | -27.8% | -44.3% |
Energy | XLE | -9.20% | -20.0% | -32.5% | -34.0% |
Financial | XLF | -8.59% | -9.23% | -39.1% | -55.5% |
Health Care | XLV | -8.53% | -8.77% | -22.3% | -34.9% |
Industrial | XLI | -8.42% | -11.2% | -26.3% | -41.8% |
Materials | XLB | -9.21% | -12.4% | -18.9% | -29.3% |
Real Estate | XLRE | -10.2% | -9.24% | -23.8% | -46.6% |
Technology | XLK | -6.98% | -7.92% | -21.8% | -35.2% |
Utilities | XLU | -11.4% | -12.8% | -26.1% | -58.5% |
Aerospace & Defense | XAR | -7.51% | -13.2% | -30.9% | -54.2% |
Biotech | XBI | -3.55% | -6.08% | -9.26% | -22.2% |
Homebuilder | XHB | -8.61% | -12.1% | -7.58% | -25.5% |
Retail | XRT | -10.4% | -11.4% | -22.9% | -28.4% |